New data show Exforge(R) (amlodipine and valsartan), a single-pill combination of the world's leading high blood pressure medicines Diovan(R) (valsartan) and amlodipine, gets nearly twice as many patients with high baseline blood pressure to a healthier blood pressure goal compared to amlodipine alone.

Results of a study in patients with baseline systolic blood pressure greater than or equal to 160 mmHg published in The Journal of the American Society of Hypertension, showed that 51.8% of patients on Exforge achieved systolic blood pressure control, defined as